Cognex en es it fr

Cognex Brand names, Cognex Analogs

Cognex Brand Names Mixture

  • No information avaliable

Cognex Chemical_Formula


Cognex RX_link

Cognex fda sheet

Cognex msds (material safety sheet)

Cognex MSDS

Cognex Synthesis Reference

No information avaliable

Cognex Molecular Weight

198.264 g/mol

Cognex Melting Point

183.5 oC

Cognex H2O Solubility

217 mg/L

Cognex State


Cognex LogP


Cognex Dosage Forms

No information avaliable

Cognex Indication

For the treatment of mild to moderate dementia of the Alzheimer's type.

Cognex Pharmacology

Tacrine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. Tacrine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Tacrine is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, tacrine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. There is no evidence that tacrine alters the course of the underlying dementing process.

Cognex Absorption

Tacrine is rapidly absorbed. Absolute bioavailability of tacrine is approximately 17 ± 13%.

Cognex side effects and Toxicity

No information avaliable

Cognex Patient Information

No information avaliable

Cognex Organisms Affected

Humans and other mammals